Compare PFE & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFE | MS |
|---|---|---|
| Founded | 1849 | 1924 |
| Country | United States | United States |
| Employees | 75000 | 83000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.2B | 255.2B |
| IPO Year | 2013 | N/A |
| Metric | PFE | MS |
|---|---|---|
| Price | $27.01 | $154.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $27.83 | ★ $177.42 |
| AVG Volume (30 Days) | ★ 31.7M | 6.4M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.30% | 2.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.36 | N/A |
| Revenue | ★ $62,579,000,000.00 | N/A |
| Revenue This Year | N/A | $12.04 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | $20.08 | ★ $17.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.92 | $94.33 |
| 52 Week High | $27.94 | $192.68 |
| Indicator | PFE | MS |
|---|---|---|
| Relative Strength Index (RSI) | 51.17 | 31.30 |
| Support Level | $26.29 | $143.34 |
| Resistance Level | $27.67 | $167.41 |
| Average True Range (ATR) | 0.52 | 5.65 |
| MACD | -0.06 | -1.09 |
| Stochastic Oscillator | 50.86 | 5.51 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.